Access to genomic testing and matched treatments remains profoundly unequal within and between countries, according to a new commission by The Lancet Oncology.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Presented at the World Cancer Congress in Hong Kong, the "Lancet Oncology Commission on Cancer Genomics and Precision Oncology" proposes a global roadmap to make oncology genomics and precision oncology more accessible, sustainable and fair. The post Cancers. The new International Commission of The Lancet Oncology is born to reduce inequalities appeared first on Daily Health.